{"id":924101,"date":"2026-01-06T08:27:49","date_gmt":"2026-01-06T13:27:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/"},"modified":"2026-01-06T08:27:49","modified_gmt":"2026-01-06T13:27:49","slug":"fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/","title":{"rendered":"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BURLINGTON, Mass., Jan.  06, 2026  (GLOBE NEWSWIRE) &#8212; Fractyl Health, Inc. (Nasdaq: GUTS) (the \u201cCompany\u201d or \u201cFractyl\u201d), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (\u201cT2D\u201d), today announced the appointment of Lara Smith Weber as Chief Financial Officer, effective January 12, 2026. Ms. Smith Weber will oversee finance, accounting, and investor relations; and will serve as a key strategic partner to the Company\u2019s executive leadership team and Board of Directors.<\/p>\n<p>Ms. Smith Weber brings more than 20 years of financial leadership experience across medtech, biotech, and other growth-oriented industries. She has a strong track record of building disciplined financial organizations, supporting transitions into commercial-stage operations, and guiding companies through periods of operational scale with increasing regulatory and public-market complexity.<\/p>\n<p>\u201cFractyl is entering a stage where disciplined execution and commercial preparedness become increasingly important,\u201d said Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of Fractyl. \u201cLara\u2019s experience building financial and operating discipline in growth-stage healthcare companies makes her well-suited to support the Company as we advance through pivotal development and prepare for commercial execution and scale.\u201d<\/p>\n<p>Most recently, Ms. Smith Weber served as Chief Financial Officer of Inari, where she completed multiple financings, strengthened the company\u2019s capital structure, and built financial systems and processes to support a growing organization. Previously, she was Chief Financial Officer of ONWARD Medical, a publicly traded medtech company listed on Euronext. Earlier in her career, Ms. Smith Weber served as U.S. Chief Financial Officer and Head of Commercial Finance at MorphoSys, where she played a key role in preparing the organization for and operating as a commercial-stage company.<\/p>\n<p>\u201cFractyl is at a pivotal moment as the Company works to redefine what is possible in the treatment of metabolic disease,\u201d said Ms. Smith Weber. \u201cThe opportunity to move beyond chronic management toward durable remission represents a meaningful shift for patients and for the healthcare system. I\u2019m excited to join the team as Fractyl advances its clinical programs and prepares for the operational and financial scale needed to support commercialization, with a focus on disciplined capital allocation and long-term value creation.\u201d<\/p>\n<p>After ten years with the Company, Lisa Davidson has resigned as Fractyl\u2019s Chief Financial Officer effective as of December 31, 2025. During her tenure, Ms. Davidson played a central role in guiding Fractyl through key periods of growth, including its initial public offering, strengthening financial and operating disciplines, and supporting the buildout and scaling of the Company\u2019s facilities and infrastructure.<\/p>\n<p>Ms. Davidson\u00a0will provide consulting services\u00a0to the Company\u00a0during this transition.<\/p>\n<p>\u201cLisa has been a steady and trusted partner to me and to the leadership team,\u201d said Dr. Rajagopalan. \u201cHer rigor, integrity, and thoughtful leadership have helped position Fractyl for its next phase, and we are grateful for her many contributions to the organization.\u201d<\/p>\n<p>\n        <strong>About Fractyl Health<\/strong><br \/>\n        <br \/>Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl\u2019s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. The Company has a robust and growing IP portfolio, with 35 granted U.S. patents and approximately 45 pending U.S. applications, along with numerous foreign issued patents and pending applications. Fractyl is based in Burlington, MA. For more information, visit\u2009<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EknEp-H2Kz1mIskA7xuWvKnXQKVFKYr3YuliaI3eJGkIc_3wm_1D6-rN67kL8LMYWGHowKj9Rm3fXr9aZXBIvtc2dS0JpCAGQT8rmGtTBP4=\" rel=\"nofollow\" target=\"_blank\"><u>www.fractyl.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements <\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the Company\u2019s executive leadership transition, including the anticipated contributions of the Company\u2019s new Chief Financial Officer. These forward-looking statements are based on management\u2019s current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially, including the Company\u2019s ability to\u00a0effect\u00a0an orderly leadership transition and execute its strategic\u00a0objectives.\u00a0Additional\u00a0risks and uncertainties are\u00a0discussed under the caption \u201cRisk Factors\u201d in our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the \u201cSEC\u201d) on November 12,\u00a02025,\u00a0and in our other filings with the SEC. These forward-looking statements are based on management\u2019s current estimates and expectations. While the Company may\u00a0elect\u00a0to update such forward-looking statements at some point in the future, the Company\u00a0disclaims\u00a0any obligation to do so, even if\u00a0subsequent\u00a0events cause its views to change.\u00a0<\/p>\n<p>\n        <strong>Contact<\/strong>\n      <\/p>\n<p>Brian Luque, Head of Investor Relations and Corporate Development<br \/>IR@fractyl.com, 951.206.1200<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzRiYmJmMzYtYzJlOC00MzJlLTliZjYtNWVjYjYwNTBhYTk3LTExOTM1ODMtMjAyNi0wMS0wNi1lbg==\/tiny\/Fractyl-Health-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BURLINGTON, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) &#8212; Fractyl Health, Inc. (Nasdaq: GUTS) (the \u201cCompany\u201d or \u201cFractyl\u201d), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (\u201cT2D\u201d), today announced the appointment of Lara Smith Weber as Chief Financial Officer, effective January 12, 2026. Ms. Smith Weber will oversee finance, accounting, and investor relations; and will serve as a key strategic partner to the Company\u2019s executive leadership team and Board of Directors. Ms. Smith Weber brings more than 20 years of financial leadership experience across medtech, biotech, and other growth-oriented industries. She has a strong track record of building disciplined financial organizations, supporting transitions into commercial-stage operations, and guiding companies through periods &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-924101","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BURLINGTON, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) &#8212; Fractyl Health, Inc. (Nasdaq: GUTS) (the \u201cCompany\u201d or \u201cFractyl\u201d), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (\u201cT2D\u201d), today announced the appointment of Lara Smith Weber as Chief Financial Officer, effective January 12, 2026. Ms. Smith Weber will oversee finance, accounting, and investor relations; and will serve as a key strategic partner to the Company\u2019s executive leadership team and Board of Directors. Ms. Smith Weber brings more than 20 years of financial leadership experience across medtech, biotech, and other growth-oriented industries. She has a strong track record of building disciplined financial organizations, supporting transitions into commercial-stage operations, and guiding companies through periods &hellip; Continue reading &quot;Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-06T13:27:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness\",\"datePublished\":\"2026-01-06T13:27:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/\"},\"wordCount\":777,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/\",\"name\":\"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=\",\"datePublished\":\"2026-01-06T13:27:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/","og_locale":"en_US","og_type":"article","og_title":"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - Market Newsdesk","og_description":"BURLINGTON, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) &#8212; Fractyl Health, Inc. (Nasdaq: GUTS) (the \u201cCompany\u201d or \u201cFractyl\u201d), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (\u201cT2D\u201d), today announced the appointment of Lara Smith Weber as Chief Financial Officer, effective January 12, 2026. Ms. Smith Weber will oversee finance, accounting, and investor relations; and will serve as a key strategic partner to the Company\u2019s executive leadership team and Board of Directors. Ms. Smith Weber brings more than 20 years of financial leadership experience across medtech, biotech, and other growth-oriented industries. She has a strong track record of building disciplined financial organizations, supporting transitions into commercial-stage operations, and guiding companies through periods &hellip; Continue reading \"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-06T13:27:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness","datePublished":"2026-01-06T13:27:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/"},"wordCount":777,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/","name":"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=","datePublished":"2026-01-06T13:27:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYxOTM0NiM3MzQzMDYyIzIxODIwMTQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fractyl-health-appoints-lara-smith-weber-as-chief-financial-officer-to-support-commercial-stage-preparedness\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/924101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=924101"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/924101\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=924101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=924101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=924101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}